| Financial Year |
March 31 2022 |
| Monetary Funds |
232,795,335.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
60,367,563.11 |
| Accounts Receivable |
206,594,043.93 |
| Advances to Suppliers |
17,848,930.17 |
| Other Receivables |
43,689,660.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
213,728,258.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,086,765.80 |
| Total Current Assets |
782,625,500.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,149,800.82 |
| Investment Properties |
-- |
| Fixed Assetes |
206,302,283.04 |
| Under-construction Projects |
308,967,070.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
86,626,314.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,032,367.12 |
| Deferred Income Tax Assets |
42,631,578.99 |
| Other Non-Current Assets |
19,905,293.82 |
| Sub-Total of Non-Current Assets |
751,767,242.54 |
| Total Assets |
1,534,392,743.20 |
| Short-Term Loans |
179,745,535.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
174,950,096.09 |
| Accounts Payable |
112,820,618.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,073,497.88 |
| Taxes Payable |
12,379,981.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
86,498,502.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,797,996.94 |
| Other Current Liabilities |
11,898,612.35 |
| Sub-Total of Current Liabilities |
657,889,464.83 |
| Long-term Loans |
118,704,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
164,470,089.22 |
| Total Liabilities |
822,359,554.05 |
| Paid-In Capital(Or Share Stock) |
206,896,400.00 |
| Capital Surplus |
258,169,917.07 |
| Surplus Reserve |
43,601,000.67 |
| LESS:Treasury Stock |
7,788,770.00 |
| Undistributed Profits |
205,143,289.12 |
| Minority Stockholder's Interest |
6,011,352.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
706,021,836.86 |
| Owner's Equity（Stockholder's Equity） |
712,033,189.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,534,392,743.20 |
